Prognosis of Heart Transplanted Patients With Heart Failure (RE-START): a National Multi-center, Retrospective-prospective, Cohort Study

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Heart transplantation is the most effective treatment for end-stage heart failure, advanced cardiomyopathy, and complex congenital heart disease with severe heart failure or hypoxia. Several clinical studies have shown significant differences in the prognosis of heart transplantation patients with different etiologies, and post-transplantation complications are an important factor affecting patient survival, and there is still a lack of overall prognostic stratification and extensive clinical studies on risk factors after heart transplantation. Therefore, this study is intended to include patients who underwent heart transplantation for different etiologies of heart failure, collect clinical data and biological samples from patients, and use various techniques to deeply interpret the risk factors affecting the prognosis of heart transplantation patients and construct a prognostic prediction model to provide specific and individualized treatment ideas and theoretical basis for improving the survival rate of patients after heart transplantation.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 3
Maximum Age: 80
Healthy Volunteers: f
View:

• Patients with end-stage heart failure presented to our hospital who are evaluated by clinicians and ethically approved for heart transplantation

• Individuals whose hearts are donated

Locations
Other Locations
China
First Affiliated Hospital of Xi'an Jiaotong University
RECRUITING
Xi'an
Contact Information
Primary
Guoliang Li
liguoliang_med@163.com
+8613759982523
Backup
Yang Yan
yangyan3@xjtu.edu.cn
+862985323865
Time Frame
Start Date: 2023-04-23
Estimated Completion Date: 2042-12-31
Participants
Target number of participants: 1000
Treatments
Heart transplantation group
Patients with heart failure of different etiologies undergoing heart transplant.
Control group
Individuals whose hearts are donated.
Sponsors
Leads: First Affiliated Hospital Xi'an Jiaotong University

This content was sourced from clinicaltrials.gov